# RCT Glargine vs NPH for Treatment of DM in Pregnancy

> **NCT06619301** · PHASE3 · RECRUITING · sponsor: **Loyola University** · enrollment: 160 (estimated)

## Conditions studied

- Diabetes Mellitus in Pregnancy
- Type 2 Diabetes Mellitus (T2DM)
- Gestational Diabetes Mellitus, Class A2

## Interventions

- **DRUG:** Insulin glargine
- **DRUG:** insulin NPH

## Key facts

- **NCT ID:** NCT06619301
- **Lead sponsor:** Loyola University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-01
- **Primary completion:** 2026-04-01
- **Final completion:** 2027-01-01
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2024-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06619301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06619301, "RCT Glargine vs NPH for Treatment of DM in Pregnancy". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT06619301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*